Use of therapeutic laser for prevention and treatment of oral mucositis

Oral mucositis (OM) affects patients who are submitted to hematopoietic stem cell transplantation (HSCT) due to high doses of chemotherapy and/or radiotherapy. The purpose of this investigation was to perform a comparative study of the frequency and evolution of OM among patients subjected to therapeutic laser and to the conventional therapy (use of mouthwash called "Mucositis Formula"). The patients were subjected to a myeloablative conditioning regimen before the allogeneic HSCT. Twenty-two patients were selected and divided into 2 groups: group I was irradiated with InGaAlP laser (660 nm) and GaAlAs laser (780 nm), 25 mW potency, 6.3J/cm² dose, in 10-s irradiation time, followed to conventional treatment; group II was subjected only to the conventional treatment. Both World Health Organization (WHO) scale and the Oral Mucositis Assessment Scale (OMAS) were used to evaluate the results. Data were analyzed by the non-parametric Wilcoxon test, with p<0.05 considered as statistically significant. Group I presented a lower frequency of OM (p=0.02) and lower mean scores, according to WHO and OMAS scales (p<0.01 and p=0.01, respectively). In conclusion, laser reduced the frequency and severity of OM, suggesting that therapeutic laser can be used both as a new form of prevention and treatment of OM.

Saved in:
Bibliographic Details
Main Authors: Khouri,Vivian Youssef, Stracieri,Ana Beatriz Pereira Lima, Rodrigues,Maria Carolina, Moraes,Daniela Aparecida de, Pieroni,Fabiano, Simões,Belinda Pinto, Voltarelli,Júlio César
Format: Digital revista
Language:English
Published: Fundação Odontológica de Ribeirão Preto 2009
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-64402009000300008
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0103-64402009000300008
record_format ojs
spelling oai:scielo:S0103-644020090003000082009-09-21Use of therapeutic laser for prevention and treatment of oral mucositisKhouri,Vivian YoussefStracieri,Ana Beatriz Pereira LimaRodrigues,Maria CarolinaMoraes,Daniela Aparecida dePieroni,FabianoSimões,Belinda PintoVoltarelli,Júlio César oral mucositis chemotherapy radiotherapy allogeneic hematopoietic stem cell transplantation therapeutic laser Oral mucositis (OM) affects patients who are submitted to hematopoietic stem cell transplantation (HSCT) due to high doses of chemotherapy and/or radiotherapy. The purpose of this investigation was to perform a comparative study of the frequency and evolution of OM among patients subjected to therapeutic laser and to the conventional therapy (use of mouthwash called "Mucositis Formula"). The patients were subjected to a myeloablative conditioning regimen before the allogeneic HSCT. Twenty-two patients were selected and divided into 2 groups: group I was irradiated with InGaAlP laser (660 nm) and GaAlAs laser (780 nm), 25 mW potency, 6.3J/cm² dose, in 10-s irradiation time, followed to conventional treatment; group II was subjected only to the conventional treatment. Both World Health Organization (WHO) scale and the Oral Mucositis Assessment Scale (OMAS) were used to evaluate the results. Data were analyzed by the non-parametric Wilcoxon test, with p<0.05 considered as statistically significant. Group I presented a lower frequency of OM (p=0.02) and lower mean scores, according to WHO and OMAS scales (p<0.01 and p=0.01, respectively). In conclusion, laser reduced the frequency and severity of OM, suggesting that therapeutic laser can be used both as a new form of prevention and treatment of OM.info:eu-repo/semantics/openAccessFundação Odontológica de Ribeirão PretoBrazilian Dental Journal v.20 n.3 20092009-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-64402009000300008en10.1590/S0103-64402009000300008
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Khouri,Vivian Youssef
Stracieri,Ana Beatriz Pereira Lima
Rodrigues,Maria Carolina
Moraes,Daniela Aparecida de
Pieroni,Fabiano
Simões,Belinda Pinto
Voltarelli,Júlio César
spellingShingle Khouri,Vivian Youssef
Stracieri,Ana Beatriz Pereira Lima
Rodrigues,Maria Carolina
Moraes,Daniela Aparecida de
Pieroni,Fabiano
Simões,Belinda Pinto
Voltarelli,Júlio César
Use of therapeutic laser for prevention and treatment of oral mucositis
author_facet Khouri,Vivian Youssef
Stracieri,Ana Beatriz Pereira Lima
Rodrigues,Maria Carolina
Moraes,Daniela Aparecida de
Pieroni,Fabiano
Simões,Belinda Pinto
Voltarelli,Júlio César
author_sort Khouri,Vivian Youssef
title Use of therapeutic laser for prevention and treatment of oral mucositis
title_short Use of therapeutic laser for prevention and treatment of oral mucositis
title_full Use of therapeutic laser for prevention and treatment of oral mucositis
title_fullStr Use of therapeutic laser for prevention and treatment of oral mucositis
title_full_unstemmed Use of therapeutic laser for prevention and treatment of oral mucositis
title_sort use of therapeutic laser for prevention and treatment of oral mucositis
description Oral mucositis (OM) affects patients who are submitted to hematopoietic stem cell transplantation (HSCT) due to high doses of chemotherapy and/or radiotherapy. The purpose of this investigation was to perform a comparative study of the frequency and evolution of OM among patients subjected to therapeutic laser and to the conventional therapy (use of mouthwash called "Mucositis Formula"). The patients were subjected to a myeloablative conditioning regimen before the allogeneic HSCT. Twenty-two patients were selected and divided into 2 groups: group I was irradiated with InGaAlP laser (660 nm) and GaAlAs laser (780 nm), 25 mW potency, 6.3J/cm² dose, in 10-s irradiation time, followed to conventional treatment; group II was subjected only to the conventional treatment. Both World Health Organization (WHO) scale and the Oral Mucositis Assessment Scale (OMAS) were used to evaluate the results. Data were analyzed by the non-parametric Wilcoxon test, with p<0.05 considered as statistically significant. Group I presented a lower frequency of OM (p=0.02) and lower mean scores, according to WHO and OMAS scales (p<0.01 and p=0.01, respectively). In conclusion, laser reduced the frequency and severity of OM, suggesting that therapeutic laser can be used both as a new form of prevention and treatment of OM.
publisher Fundação Odontológica de Ribeirão Preto
publishDate 2009
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-64402009000300008
work_keys_str_mv AT khourivivianyoussef useoftherapeuticlaserforpreventionandtreatmentoforalmucositis
AT stracierianabeatrizpereiralima useoftherapeuticlaserforpreventionandtreatmentoforalmucositis
AT rodriguesmariacarolina useoftherapeuticlaserforpreventionandtreatmentoforalmucositis
AT moraesdanielaaparecidade useoftherapeuticlaserforpreventionandtreatmentoforalmucositis
AT pieronifabiano useoftherapeuticlaserforpreventionandtreatmentoforalmucositis
AT simoesbelindapinto useoftherapeuticlaserforpreventionandtreatmentoforalmucositis
AT voltarellijuliocesar useoftherapeuticlaserforpreventionandtreatmentoforalmucositis
_version_ 1756404475265810432